EFFECT OF LEUPROLIDE ACETATE (LA) IN PATIENTS WITH MODERATE-TO-SEVERE FUNCTIONAL BOWEL-DISEASE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY

被引：0
|
作者：
MATHIAS, JR [1 ]
CLENCH, MH [1 ]
REEVESDARBY, VG [1 ]
ROBERTS, PH [1 ]
SMITH, LL [1 ]
机构：
[1] UNIV TEXAS,MED BRANCH,DEPT INTERNAL MED,GALVESTON,TX 77550
来源：
GASTROENTEROLOGY | 1993年 / 104卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A548 / A548
页数：1
相关论文
共 50 条
  • [1] EFFECT OF LEUPROLIDE ACETATE IN PATIENTS WITH MODERATE TO SEVERE FUNCTIONAL BOWEL-DISEASE - DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MATHIAS, JR
    CLENCH, MH
    REEVESDARBY, VG
    FOX, LM
    HSU, PH
    ROBERTS, PH
    SMITH, LL
    STIGLICH, NJ
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (06) : 1155 - 1162
  • [2] EFFECT OF LEUPROLIDE ACETATE (LA) IN PATIENTS WITH FUNCTIONAL BOWEL-DISEASE - LONG-TERM FOLLOW-UP AFTER A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MATHIAS, JR
    CLENCH, MH
    ROBERTS, PH
    REEVESDARBY, VG
    GASTROENTEROLOGY, 1993, 104 (04) : A549 - A549
  • [3] Effects of leuprolide acetate (LA) on functional bowel disease (FBD): A multicenter, double-blind, placebo-controlled study.
    Mathias, JR
    Clench, MH
    Abell, TE
    Koch, KL
    Lehman, GA
    Robinson, M
    Rothstein, RD
    Snape, WJ
    GASTROENTEROLOGY, 1997, 112 (04) : A784 - A784
  • [4] EFFECT OF LEUPROLIDE ACETATE IN PATIENTS WITH FUNCTIONAL BOWEL-DISEASE - LONG-TERM FOLLOW-UP AFTER DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    MATHIAS, JR
    CLENCH, MH
    ROBERTS, PH
    REEVESDARBY, VG
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (06) : 1163 - 1170
  • [5] Effect of Leuprolide Acetate in Treatment of Abdominal Pain and Nausea in Premenopausal Women with Functional Bowel Disease: A Double-Blind, Placebo-Controlled, Randomized Study
    John R. Mathias
    Mary H. Clench
    Thomas L. Abell
    Kenneth L. Koch
    Glen Lehman
    Malcolm Robinson
    Robin Rothstein
    William J. Snape
    Digestive Diseases and Sciences, 1998, 43 : 1347 - 1355
  • [6] Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease - A double-blind, placebo-controlled, randomized study
    Mathias, JR
    Clench, MH
    Abell, TL
    Koch, KL
    Lehman, G
    Robinson, M
    Rothstein, R
    Snape, WJ
    DIGESTIVE DISEASES AND SCIENCES, 1998, 43 (06) : 1347 - 1355
  • [7] A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn's Disease
    Targan, Stephan R.
    Feagan, Brian
    Vermeire, Severine
    Panaccione, Remo
    Melmed, Gil Y.
    Landers, Carol
    Li, Dalin
    Russell, Chris
    Newmark, Richard
    Zhang, Nan
    Chon, Yun
    Hsu, Yi-Hsiang
    Lin, Shao-Lee
    Klekotka, Paul
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 (11): : 1599 - 1607
  • [8] Onercept for moderate-to-severe Crohn's disease: A randomized, double-blind, placebo-controlled trial
    Rutgeerts, Paul
    Sandborn, William J.
    Fedorak, Richard N.
    Rachmilewitz, Daniel
    Tarabar, Dino
    Gibson, Peter
    Nielsen, Ole Haagen
    Wild, Gary
    Schreiber, Stefan
    Rossi, Claudia Pena
    Zignani, Monia
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2006, 4 (07) : 888 - 893
  • [9] Tralokinumab for moderate-to-severe UC: a randomised, double-blind, placebo-controlled, phase IIa study
    Danese, Silvio
    Rudzinski, Janusz
    Brandt, Wolfgang
    Dupas, Jean-Louis
    Peyrin-Biroulet, Laurent
    Bouhnik, Yoram
    Kleczkowski, Dariusz
    Uebel, Peter
    Lukas, Milan
    Knutsson, Mikael
    Erlandsson, Fredrik
    Hansen, Mark Berner
    Keshav, Satish
    GUT, 2015, 64 (02) : 243 - 249
  • [10] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Tyring, Stephen K. K.
    Rich, Phoebe
    Tada, Yayoi
    Beeck, Stefan
    Messina, Izabella
    Liu, Jie
    Huang, Xiaohong
    Shumack, Stephen
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 595 - 608
12345